These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10754709)

  • 1. A novel self emulsifying parenteral drug delivery system.
    Krishna G; Sheth BB
    PDA J Pharm Sci Technol; 1999; 53(4):168-76. PubMed ID: 10754709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lyophilization on parenteral emulsions.
    Krishna G; Sheth BB
    PDA J Pharm Sci Technol; 1999; 53(6):318-23. PubMed ID: 10754731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Particle size reduction of emulsions by formulation design. I: Effect of polyhydroxy alcohols.
    Chanana GD; Sheth BB
    J Parenter Sci Technol; 1993; 47(3):130-4. PubMed ID: 8360805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Particle size reduction of emulsions by formulation design-II: effect of oil and surfactant concentration.
    Chanana GD; Sheth BB
    PDA J Pharm Sci Technol; 1995; 49(2):71-6. PubMed ID: 7780748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation optimization of self-emulsifying preparations of puerarin through self-emulsifying performances evaluation in vitro and pharmacokinetic studies in vivo.
    Quan DQ; Xu GX
    Yao Xue Xue Bao; 2007 Aug; 42(8):886-91. PubMed ID: 17944241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving emulsification efficacy of lecithin by formulation design. I: Effect of adding a secondary surfactant.
    Krishna G; Wood GC; Sheth BB
    PDA J Pharm Sci Technol; 1998; 52(6):331-6. PubMed ID: 10050132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emulsification and solubilisation properties of polyglycolysed oils in self-emulsifying formulations.
    Devani M; Ashford M; Craig DQ
    J Pharm Pharmacol; 2004 Mar; 56(3):307-16. PubMed ID: 15025855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS).
    Rahman MA; Hussain A; Hussain MS; Mirza MA; Iqbal Z
    Drug Dev Ind Pharm; 2013 Jan; 39(1):1-19. PubMed ID: 22372916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of isradipine loaded self-nano emulsifying powders for improved oral delivery: in vitro and in vivo evaluation.
    Ramasahayam B; Eedara BB; Kandadi P; Jukanti R; Bandari S
    Drug Dev Ind Pharm; 2015 May; 41(5):753-63. PubMed ID: 24641324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replacing PEG-surfactants in self-emulsifying drug delivery systems: Surfactants with polyhydroxy head groups for advanced cytosolic drug delivery.
    Friedl JD; Jörgensen AM; Nguyen Le NM; Steinbring C; Bernkop-Schnürch A
    Int J Pharm; 2022 Apr; 618():121633. PubMed ID: 35304244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems.
    Balakrishnan P; Lee BJ; Oh DH; Kim JO; Lee YI; Kim DD; Jee JP; Lee YB; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2009 Jun; 374(1-2):66-72. PubMed ID: 19446761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation development and pharmacokinetics of puerarin self-emulsifying drug delivery systems.
    Dong-Qin Q; Gui-Xia X; Xiang-Gen W
    PDA J Pharm Sci Technol; 2007; 61(1):37-43. PubMed ID: 17390702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of a mixture experimental design in the optimization of a self-emulsifying formulation with a high drug load.
    Gao P; Witt MJ; Haskell RJ; Zamora KM; Shifflett JR
    Pharm Dev Technol; 2004 Aug; 9(3):301-9. PubMed ID: 15458235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxicity assessment of lipid-based self-emulsifying drug delivery system with Caco-2 cell model: Cremophor EL as the surfactant.
    Bu P; Narayanan S; Dalrymple D; Cheng X; Serajuddin AT
    Eur J Pharm Sci; 2016 Aug; 91():162-71. PubMed ID: 27328127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emulsion forming drug delivery system for lipophilic drugs.
    Wadhwa J; Nair A; Kumria R
    Acta Pol Pharm; 2012; 69(2):179-91. PubMed ID: 22568032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions.
    Li P; Ghosh A; Wagner RF; Krill S; Joshi YM; Serajuddin AT
    Int J Pharm; 2005 Jan; 288(1):27-34. PubMed ID: 15607255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between internal phase volume and emulsion stability: the cetyl alcohol/stearyl alcohol system.
    Sepulveda E; Kildsig DO; Ghaly ES
    Pharm Dev Technol; 2003 Aug; 8(3):263-75. PubMed ID: 12901692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal solid delivery of epigallocatechin-3-gallate using self-double-emulsifying drug delivery system as vehicle: Formulation, evaluation and vesicle-skin interaction.
    Hu C; Gu C; Fang Q; Wang Q; Xia Q
    J Biomater Appl; 2016 Feb; 30(7):1080-91. PubMed ID: 26637442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of emulsion-based drug delivery systems on intestinal permeability and drug release kinetics.
    Buyukozturk F; Benneyan JC; Carrier RL
    J Control Release; 2010 Feb; 142(1):22-30. PubMed ID: 19850092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and molecular interpretation of the effects of drug incorporation on the self-emulsification process using spectroscopic, micropolarimetric and microscopic measurements.
    Mercuri A; Belton PS; Royall PG; Barker SA
    Mol Pharm; 2012 Sep; 9(9):2658-68. PubMed ID: 22913291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.